Context
The recent acknowledgment by AstraZeneca, the developer and manufacturer of the Covishield Covid vaccine, regarding the possibility of Thrombosis with Thrombocytopenia Syndrome (TTS) as a side effect has raised significant ethical concerns. This development has prompted a reassessment of the vaccine's safety and efficacy, highlighting complex ethical dilemmas in public health decision-making.
Verifying, please be patient.